Subscribe free

HPB & Spleen ·

Liver Resection for Colorectal Metastases Sets New Outcomes Benchmark

Liver resection remains a gold standard for colorectal liver metastases, providing critical data for patient selection and surgical outcomes.

  • 90-day mortality rate is under 5% across most groups, signaling low operative risk.
  • One-year overall survival exceeds 85% for most subgroups, but drops to 78% for patients with 10 or more metastases.

Timely assessment of these benchmarks will guide surgical decision-making against emerging alternatives like thermal ablation and transplantation.

  • Five-year overall survival rates are: ≥45% for solitary synchronous, ≥58% for solitary metachronous metastases; ≥28% for more than 3 metastases.

Multicenter Study by Viganò L, Risi L (…) Adam R et 12 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →